Clinical Trials Browser

OTHER × Interventional × zipalertinib × Clear all

NCT07229339 2026-02-05

Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer

Phase 2 Not yet recruiting

Lung Non-Squamous Non-Small Cell Carcinoma